Aptar CSP Technologies’ Activ-Blister Solutions Now Available for Manufacturing in the EMEA Region
Aptar CSP Technologies recently announced a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister technology globally and is the result of a three-way collaboration between Aptar CSP, Uhlmann (a leading pharmaceutical packaging equipment manufacturer), and Ivers-Lee, www.iverslee.com, (a local contract manufacturing organization).
This collaboration consists of a fully automated Uhlmann blister machine validated to package oral solid dose drug products with Activ-Blister Solutions heat-staked to the foil at a rate of up to 250 blisters per minute (Figure 1). The equipment is designed to integrate Activ-Blister technology into the blister cavity with precision placement (Figure 2). The equipment has been fully validated and is in place at Ivers-Lee, a CMO capable of manufacturing Activ-Blister solutions from R&D to commercialization. A CMO in EMEA will support regional customers and ensure speed-to-market.
Figure 1. Uhlmann Blister Machine Used to Manufacture Activ-Blister™ Solutions at Ivers-Lee
Figure 2. Activ-Blister™ technology remains attached to foil backing when blister is opened for enhanced patient safety.
“Expanding global manufacturing sites for Activ-Blister technology reflects our commitment to delivering global access to innovative active material science solutions for patients and consumers,” said Badre Hammond, VP Commercial Operations and GM APAC, Aptar CSP Technologies. “With manufacturing capabilities now available in in both the US and EMEA, we will turn our attention to bringing production of this technology to the Asia market.”
Activ-Blister Solutions integrates Aptar CSP’s proprietary 3-Phase Activ-Polymer™ platform technology into individual blister cavities to provide precision microclimate protection for sensitive drug products. This technology can be customized specifically for the drug developer’s formulation to provide a broad spectrum of specific drug protection, including moisture adsorption and oxygen and odor scavenging. The technology can also scavenge volatile organic compounds (VOCs) and emit aromas.
Representatives from Aptar CSP Technologies will be available at Pharmapack on May 18-19 in Paris, France, to provide more information on this collaboration and the opportunities it presents. Visit Aptar at booth E46 or contact Francois Bidet at +33 6 2078 8153 or Francois.Bidet@Aptar.com to schedule a meeting.
Aptar CSP Technologies is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions and services. Aptar CSP Technologies leverages its active material science expertise to transform ideas into market opportunities, accelerate and de-risks the product development process, and provide complete solutions that improve consumers’ and patients’ lives. The company offers a complete set of services from concept ideation, to design and engineering, to product development, global production, quality control, and regulatory support that results in expedited speed-to-market. For more information, visit www.csptechnologies.com and www.aptar.com.
Total Page Views: 764
